Related Experiment Video
Updated: Feb 21, 2026

07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.7K
Malignant Retroperitoneal Extra-Gastrointestinal Stromal Tumor: A Unique Entity
Shalini Thapar Laroia1, Taruna Yadav1, Archana Rastogi2
1Department of Radiology, Institute of Liver and Biliary Sciences, Sector D-1, Vasant Kunj, New Delhi 110070, India.
World Journal of Oncology
|October 7, 2017
Summary
Extra-gastrointestinal stromal tumors (EGISTs) are rare mesenchymal neoplasms distinct from gastrointestinal stromal tumors (GISTs). Early recognition of these retroperitoneal EGISTs is crucial due to their aggressive nature and poor prognosis.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Extra-gastrointestinal stromal tumors (EGISTs) are rare mesenchymal neoplasms originating outside the gastrointestinal tract.
- Distinguishing EGISTs from gastrointestinal stromal tumors (GISTs) is critical due to differing prognoses and management strategies.
- EGISTs share similar histology and immunohistochemistry with GISTs but present in extraluminal locations like the omentum, mesentery, and retroperitoneum.
Observation:
- A rare case of primary malignant EGIST in the retroperitoneum is presented.
- The retroperitoneal EGIST initially appeared as a soft tissue mass on radiological evaluation.
- Histopathological and immunohistochemical analyses were essential for definitive diagnosis, revealing the tumor as an EGIST.
Findings:
- Retroperitoneal EGISTs represent an extremely rare subgroup of these extraluminal tumors.
- Morphological and immunohistochemical studies are indispensable for accurate EGIST classification.
- The presented case highlights the diagnostic challenge posed by EGISTs, often requiring detailed pathological examination.
Implications:
- Radiologists, pathologists, and oncologists must be aware of EGISTs' distinct clinical behavior and presentation.
- Early diagnosis and prompt management of EGISTs are vital for improving patient outcomes.
- Understanding the unique characteristics of EGISTs, particularly those in the retroperitoneum, can lead to better therapeutic strategies and improved prognosis.
Related Concept Videos
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K

